Training Example: HARVONI – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

HARVONI

(https://harvoni.com) 📸 Data Snapshot: May 30, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) | Patient Site (https://harvoni.com)
Title

HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) | Patient Site

Meta

Discover HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg), a prescription medicine used to treat adults with chronic Hep C. See Important Safety Information, including Important Warning.

H1 I AM HEP CURED
H2 I LET GO OF THE UNCERTAINTIES OF HEP C
H2 Important Safety Information
H2 Financial Resources
H2 Support Path Navigators can help you with:
H2 Important Safety Information
H2 Important Safety Information
H3 LEARN ABOUT
NAV_HEADER_REPEATED Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets (https://harvoni.com/discover-harvoni/about-harvoni/)
Title

Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

H2 Page not found
H2 Important Safety Information
H2 Important Safety Information
NAV_HEADER_REPEATED Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets (https://harvoni.com/getting-started/real-patient-stories/)
Title

Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

H2 Page not found
H2 Important Safety Information
H2 Important Safety Information
NAV_HEADER_REPEATED Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets (https://harvoni.com/getting-started/find-a-specialist/)
Title

Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

H2 Page not found
H2 Important Safety Information
H2 Important Safety Information
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://harvoni.com) HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) | Patient Site

                            
0 chars
SUB-PAGE · THIN (https://harvoni.com/discover-harvoni/about-harvoni/) Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

                            
0 chars
SUB-PAGE · THIN (https://harvoni.com/getting-started/real-patient-stories/) Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

                            
0 chars
SUB-PAGE · THIN (https://harvoni.com/getting-started/find-a-specialist/) Page Not Found | HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

                            
0 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
0Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
/discover-harvoni/about-harvoni/ 0 0
/getting-started/real-patient-stories/ 0 0
/getting-started/find-a-specialist/ 0 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)
/discover-harvoni/about-harvoni/ — no schema detected (entity gap)
/getting-started/real-patient-stories/ — no schema detected (entity gap)
/getting-started/find-a-specialist/ — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: HARVONI (harvoni.com)

https://harvoni.com 📍 Industry: Medical Devices, Pharma & Biotech
87 BS / 100

Harvoni.com is a hollow marketing shell where 75% of the infrastructure is broken and 100% of the remaining content is emotional fluff. It scores an 87 because it attempts to signal medical authority while failing basic technical and informational requirements. The distance between the cure-based H1 and the ‘Page Not Found’ reality is the definition of digital bullshit.

Info Density Power-words vs. Substance ratio.
27
90% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
20
100% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
12
60% BS
Commodity Fingerprint Detection of industry clichés/templates.
13
87% BS
Identity & Authority Expert verifiability & Schema depth.
15
100% BS

Immediately fix the technical architecture to ensure that pages like ‘About Harvoni’ and ‘Patient Stories’ actually contain content instead of 404 errors. Replace the emotional H1 and H2 slogans with a headline that includes clinical efficacy rates (e.g., ‘99% Cure Rate’). Implement Organization and Drug schema to provide a verifiable digital footprint to Gilead Sciences. Add direct, outbound links to peer-reviewed clinical data and the FDA label to satisfy the missing_elements of specific regulatory clearance.

The site content perfectly matches the Pharma & Biotech industry, specifically the Hepatitis C therapeutic area as indicated by the drug name ledipasvir and sofosbuvir in the meta titles. However, the site functions more as a generic patient portal than a technical medical resource.

“The score of 87 is primarily driven by Semantic Coherence and Identity/Authority failures. The total absence of sub-page content (20/20 on drift) and the lack of structured data or verifiable experts (15/15) create an environment of maximum suspicion. Information density also contributed heavily (27/30) as the crawler found zero characters of substantive body text to back up the bold H1 claims.”

Verified Analysis Date: May 30, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Brand AI Reputation